Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Cancer|January 19, 2012
HER-2 pulsed dendritic cell vaccine can eliminate HER-2 expression and impact ductal carcinoma in situAnupama Sharma, Ursula Koldovsky, Shuwen Xu, et al.
Viruses|July 27, 2022
Cardiopulmonary Injury in the Syrian Hamster Model of COVID-19Yi Xue, Dong Yang, Peter Vogel, et al.
Breast Cancer Research : BCR|May 23, 2015
Anti-HER2 CD4(+) T-helper type 1 response is a novel immune correlate to pathologic response following neoadjuvant therapy in HER2-positive breast cancerJashodeep Datta, Erik Berk, Shuwen Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 15, 2016
Dendritic Cell Vaccination Enhances Immune Responses and Induces Regression of HER2pos DCIS Independent of Route: Results of Randomized Selection Design TrialLea Lowenfeld, Rosemarie Mick, Jashodeep Datta, et al.
Critical Care Medicine|August 16, 2014
Deficiency of the two-pore-domain potassium channel TREK-1 promotes hyperoxia-induced lung injuryAndreas Schwingshackl, Bin Teng, Patrudu Makena, et al.
Oncoimmunology|September 22, 2017
Addition of anti-estrogen therapy to anti-HER2 dendritic cell vaccination improves regional nodal immune response and pathologic complete response rate in patients with ERpos/HER2pos early breast cancerLea Lowenfeld, Salman Zaheer, Crystal Oechsle, et al.
European Journal of Human Genetics : EJHG|October 10, 2013
Mutations in SH3PXD2B cause Borrone dermato-cardio-skeletal syndromeGabrielle R Wilson, Jasmine Sunley, Katherine R Smith, et al.
American Journal of Human Genetics|April 9, 2011
Human and mouse mutations in WDR35 cause short-rib polydactyly syndromes due to abnormal ciliogenesisPleasantine Mill, Paul J Lockhart, Elizabeth Fitzpatrick, et al.
Oncoimmunology|October 10, 2015
Progressive loss of anti-HER2 CD4+ T-helper type 1 response in breast tumorigenesis and the potential for immune restorationJashodeep Datta, Cinthia Rosemblit, Erik Berk, et al.
Orphanet Journal of Rare Diseases|March 29, 2014
Expanding the phenotypic spectrum of ARID1B-mediated disorders and identification of altered cell-cycle dynamics due to ARID1B haploinsufficiencyJoe C H Sim, Susan M White, Elizabeth Fitzpatrick, et al.
Pageof 7